Related Experiment Video
Updated: Jul 10, 2026

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling
Published on: March 20, 2018
Anti-clastogenic effect of magnolol on benzo(a)pyrene-induced clastogenicity in mice
Junichiro Saito1, Kiyoshi Shibuya, Hisamitsu Nagase
1Drug Safety Research Laboratories, Astellas Pharma Inc. 1-8, Azusawa 1-chome, Itabashi-ku, Tokyo 174-8511, Japan. junichiroh.saitoh@jp.astellas.com
Abstract:
It was previously reported that magnolol strongly inhibited the mutagenicity induced by the indirect mutagens [benzo(a)pyrene (B(a)P), 2-amino-3-methylimidazo[4,5-f]quinoline (IQ), 2-aminodipyrido[1,2-a:3',2'-d]imidazole (Glu-P-2), 2-aminoanthracene (2AA), and 7,12-dimethylbenz[a]anthracene (DMBA)] in Salmonella typhimurium TA98 and TA100 in the Ames test, and that the mechanism of this anti-mutagenic effect may involve the inhibition of the metabolic activation of indirect mutagen enzymes. In this study, the in vivo anti-clastogenic effect of magnolol against clastogenicity induced by B(a)P was evaluated using the micronucleus test in mice. Animals were treated with an oral administration of magnolol (1, 10, and 100 mg/kg) at -24, 0, 24, 48, 72, and 96 h before a single intraperitoneal injection of B(a)P. Peripheral blood specimens were prepared 48 h after administration of B(a)P, and analyzed by the acridine orange (AO) technique. The results indicated that magnolol inhibited clastogenicity induced by B(a)P at various administration times. In order to elucidate the mechanism behind this effect, we measured the activity of the detoxifying enzymes [UDP-glucuronosyltransferase (UGT) and glutathione-S-transferase (GST)] and antioxidative enzymes [superoxide dismutase (SOD) and catalase] in the liver when treated with an oral administration of magnolol at various administration times. Its effect on clastogenicity created by exposure to oxidative DNA damage-inducing X-ray irradiation was also evaluated using the micronucleus test in mice. Results showed that magnolol increased the activity of both UGT and SOD enzymes, and also inhibited the clastogenicity induced by X-ray irradiation. Magnolol had an anti-clastogenic effect on B(a)P in the micronucleus test as well as an anti-mutagenic effect on indirect mutagens in the Ames test. The anti-clastogenic effect of magnolol was also suggested by the increases in UGT and SOD enzyme activity, and by the attenuation of oxidative damage induced by X-ray irradiation.
Insights
Magnolol demonstrates significant anti-clastogenic effects in vivo, protecting against DNA damage induced by benzo(a)pyrene and X-ray irradiation. This protective action is linked to enhanced detoxifying and antioxidative enzyme activity.
Area of Science:
- Pharmacology
- Toxicology
- Genetics
Background:
- Magnolol previously showed anti-mutagenic properties against indirect mutagens in Ames tests.
- The mechanism was hypothesized to involve inhibition of metabolic activation of mutagens.
Purpose of the Study:
- To evaluate the in vivo anti-clastogenic effect of magnolol against benzo(a)pyrene (B(a)P) induced clastogenicity.
- To investigate the underlying mechanisms, including effects on detoxifying and antioxidative enzymes.
- To assess magnolol's protective effects against X-ray irradiation-induced clastogenicity.
Main Methods:
- In vivo micronucleus test in mice to assess anti-clastogenic effects.
- Oral administration of magnolol at various doses and time points relative to B(a)P injection or X-ray irradiation.
- Analysis of peripheral blood for micronuclei using the acridine orange (AO) technique.
- Measurement of hepatic enzyme activities: UDP-glucuronosyltransferase (UGT), glutathione-S-transferase (GST), superoxide dismutase (SOD), and catalase.
Main Results:
- Magnolol significantly inhibited B(a)P-induced clastogenicity in a time-dependent manner.
- Magnolol administration increased the activity of UDP-glucuronosyltransferase (UGT) and superoxide dismutase (SOD) enzymes.
- Magnolol also demonstrated a protective effect against clastogenicity induced by X-ray irradiation, suggesting a role in mitigating oxidative DNA damage.
Conclusions:
- Magnolol exhibits in vivo anti-clastogenic activity against B(a)P and X-ray induced DNA damage.
- The observed effects are associated with enhanced activity of detoxifying (UGT) and antioxidative (SOD) enzymes.
- Magnolol represents a potential therapeutic agent for mitigating genotoxicity and oxidative stress.
Related Concept Videos
Drugs that Destabilize Microtubules
Drugs that Stabilize Microtubules
Mutagenicity and Carcinogenicity
Teratogenicity
In vitro Mutagenesis

